Natixis’s AdaptHealth AHCO Stock Holding History

Natixis’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$361K	Sell	30,300 -259,700	-90%	-$2.66M	﹤0.01%	858
2025 Q4	$2.89M	Buy	+290,000	New	+$2.77M	0.01%	554
2022 Q4	–	Sell	-94,000	Closed	-$1.76M	–	1078
2022 Q3	$1.76M	Sell	94,000 -26,000	-22%	-$534K	0.01%	634
2022 Q2	$2.17M	Buy	+120,000	New	+$1.95M	0.01%	648

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Natixis's AHCO Position: Q1 2026 in Review

Natixis reduced its AdaptHealth (AHCO) stake by 90% in Q1 2026, selling an estimated $2.66M and leaving 30,300 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #858.

Natixis first reported a position in AHCO in Q2 2022 and has held it in 4 quarters since. The position peaked at $2.89M in Q4 2025. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

Natixis held 30,300 shares of AdaptHealth worth $361K as of Q1 2026.
Natixis sold 259,700 AdaptHealth shares in Q1 2026, an estimated $2.66M.
AdaptHealth made up ﹤0.01% of Natixis's portfolio in Q1 2026, its #858 holding.
Natixis first reported a position in AdaptHealth in Q2 2022 and has held it in 4 quarters since.
Natixis's AdaptHealth position peaked at $2.89M in Q4 2025.
241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.